Table of Contents
ISRN Vascular Medicine
Volume 2013 (2013), Article ID 985743, 10 pages
http://dx.doi.org/10.1155/2013/985743
Research Article

Association of Leukotriene Gene Variants and Plasma LTB4 Levels with Coronary Artery Disease in Asian Indians

1Mary and Garry Weston Functional Genomics Unit, Thrombosis Research Institute, Narayana Hrudayalaya 258/A, Bommasandra Industrial Area, Anekal Taluk, Bangalore, Karnataka 560099, India
2Thrombosis Research Institute, Bangalore 560099, India
3Thrombosis Research Institute, London, SW3 6LR, UK

Received 24 April 2013; Accepted 14 May 2013

Academic Editors: D. Guidolin, A. Mugge, B. Tesfamariam, and C.-C. Wu

Copyright © 2013 Jiny Nair et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Yusuf, S. Hawken, and S. Ounpuu, “Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study,” The Lancet, vol. 364, no. 9450, pp. 937–952, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Steinberg, “Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime,” Nature Medicine, vol. 8, no. 11, pp. 1211–1217, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Peters-Golden and W. R. Henderson Jr., “Leukotrienes,” The New England Journal of Medicine, vol. 357, no. 18, pp. 1841–1854, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. C. D. Sadik and A. D. Luster, “Lipid-cytokine-chemokine cascades orchestrate leukocyte recruitment in inflammation,” Journal of Leukocyte Biology, vol. 91, no. 2, pp. 207–215, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Bäck and G. K. Hansson, “Leukotriene receptors in atherosclerosis,” Annals of Medicine, vol. 38, no. 7, pp. 493–502, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Mehrabian and H. Allayee, “5-Lipoxygenase and atherosclerosis,” Current Opinion in Lipidology, vol. 14, no. 5, pp. 447–457, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Riccioni, A. Zanasi, N. Vitulano, B. Mancini, and N. D'Orazio, “Leukotrienes in atherosclerosis: new target insights and future therapy perspectives,” Mediators of Inflammation, vol. 2009, Article ID 737282, 6 pages, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Di Gennaro, D. Wagsáter, M. I. Máyránpáá et al., “Increased expression of leukotriene C4 synthase and predominant formation of cysteinyl-leukotrienes in human abdominal aortic aneurysm,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 49, pp. 21093–21097, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Spanbroek, R. Gräbner, K. Lötzer et al., “Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 3, pp. 1238–1243, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Qiu, A. Gabrielsen, H. E. Agardh et al., “Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 21, pp. 8161–8166, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Helgadottir, S. Gretarsdottir, D. St. Clair et al., “Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population,” American Journal of Human Genetics, vol. 76, no. 3, pp. 505–509, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Helgadottir, A. Manolescu, G. Thorleifsson et al., “The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke,” Nature Genetics, vol. 36, no. 3, pp. 233–239, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Helgadottir, A. Manolescu, A. Helgason et al., “A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction,” Nature Genetics, vol. 38, no. 1, pp. 68–74, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Allayee, A. Baylin, J. Hartiala et al., “Nutrigenetic association of the 5-Lipoxygenase gene with myocardial infarction,” American Journal of Clinical Nutrition, vol. 88, no. 4, pp. 934–940, 2008. View at Google Scholar · View at Scopus
  15. J. H. Dwyer, H. Allayee, K. M. Dwyer et al., “Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis,” The New England Journal of Medicine, vol. 350, no. 1, pp. 29–37, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. D. M. Iovannisci, E. J. Lammer, L. Steiner et al., “Association between a leukotriene C4 synthase gene promoter polymorphism and coronary artery calcium in young women: the Muscatine study,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 2, pp. 394–399, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. W. Koch, P. Hoppmann, J. C. Mueller, A. Schömig, and A. Kastrati, “No association of polymorphisms in the gene encoding 5-lipoxygenase-activating protein and myocardial infarction in a large central European population,” Genetics in Medicine, vol. 9, no. 3, p. 187, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Lõhmussaar, A. Gschwendtner, J. C. Mueller et al., “ALOX5AP gene and the PDE4D gene in a central European population of stroke patients,” Stroke, vol. 36, no. 4, pp. 731–736, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Y. L. Zee, S. Cheng, H. H. Hegener, H. A. Erlich, and P. M. Ridker, “Genetic variants of arachidonate 5-lipoxygenase-activating protein, and risk of incident myocardial infarction and ischemic stroke: a nested case-control approach,” Stroke, vol. 37, no. 8, pp. 2007–2011, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Shanker, A. Maitra, V. S. Rao et al., “Rationale, design and preliminary findings of the Indian atherosclerosis research study,” Indian Heart Journal, vol. 62, no. 4, pp. 286–295, 2010. View at Google Scholar · View at Scopus
  21. N. K. Kumar, “Bioethics activities in India,” Eastern Mediterranean Health Journal, vol. 12, no. 1, pp. S56–S65, 2006. View at Google Scholar · View at Scopus
  22. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at Google Scholar · View at Scopus
  23. Z. Xu and J. A. Taylor, “SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies,” Nucleic Acids Research, vol. 37, no. 2, pp. W600–W605, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Yuan, J. Chiou, W. Tseng et al., “FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization,” Nucleic Acids Research, vol. 34, pp. W635–W641, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. S. A. Miller, D. D. Dykes, and H. F. Polesky, “A simple salting out procedure for extracting DNA from human nucleated cells,” Nucleic Acids Research, vol. 16, no. 3, article 1215, 1988. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Sham, J. S. Bader, I. Craig, M. O'Donovan, and M. Owen, “DNA pooling: a tool for large-scale association studies,” Nature Reviews Genetics, vol. 3, no. 11, pp. 862–871, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Wang, K. Chuang, M. Ahluwalia et al., “High-throughput SNP genotyping by single-tube PCR with Tm-shift primers,” BioTechniques, vol. 39, no. 6, pp. 885–892, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Haribabu, “Leukotrienes: novel targets for vascular disease,” Discovery Medicine, vol. 4, pp. 281–287, 2004. View at Google Scholar
  29. W. Bodmer and C. Bonilla, “Common and rare variants in multifactorial susceptibility to common diseases,” Nature Genetics, vol. 40, no. 6, pp. 695–701, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. K. A. B. Goddard, P. J. Hopkins, J. M. Hall, and J. S. Witte, “Linkage disequilibrium and allele-frequency distributions for 114 single-nucleotide polymorphisms five populations,” American Journal of Human Genetics, vol. 66, no. 1, pp. 216–234, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Roberts and A. F. R. Stewart, “9p21 and the genetic revolution for coronary artery disease,” Clinical Chemistry, vol. 58, no. 1, pp. 104–112, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Shea, R. Ottman, and C. Gabrieli, “Family history as an independent risk factor for coronary artery disease,” Journal of the American College of Cardiology, vol. 4, no. 4, pp. 793–801, 1984. View at Google Scholar · View at Scopus
  33. G. Wang, Y. Wang, H. Sun et al., “Variants of the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and risk of ischemic stroke in Han Chinese of eastern China,” Journal of Biomedical Research, vol. 25, no. 5, pp. 319–327, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Hartiala, D. Li, D. V. Conti et al., “Genetic contribution of the leukotriene pathway to coronary artery disease,” Human Genetics, vol. 129, no. 6, pp. 617–627, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. D. R. Crosslin, S. H. Shah, S. C. Nelson et al., “Genetic effects in the leukotriene biosynthesis pathway and association with atherosclerosis,” Human Genetics, vol. 125, no. 2, pp. 217–229, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Stanke-Labesque, J. L. Pepin, T. de Jouvencel, C. Arnaud, J. P. Baguet et al., “Leukotriene B4 pathway activation and atherosclerosis in obstructive sleep apnea,” Journal of Lipid Research, vol. 53, pp. 1944–1951, 2012. View at Google Scholar
  37. D. M. Tobin, F. J. Roca, S. F. Oh et al., “Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections,” Cell, vol. 148, no. 3, pp. 434–446, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. A. N. Zagryagskaya, D. A. Aleksandrov, M. A. Pushkareva, S. I. Galkina, Z. V. Grishina, and G. F. Sud'Ina, “Biosynthesis of leukotriene B4 in human polymorphonuclear leukocytes: regulation by cholesterol and other lipids,” Journal of Immunotoxicology, vol. 5, no. 4, pp. 347–352, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Choi, H. J. Jeon, J. Park et al., “Anti-atherogenic effect of BHB-TZD having inhibitory activities on cyclooxygenase and 5-lipoxygenase in hyperlipidemic mice,” Atherosclerosis, vol. 212, no. 1, pp. 146–152, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. E. P. Hong and J. W. Park, “Sample size and statistical power calculation in genetic association studies,” Genomics & Informatics, vol. 10, pp. 117–122, 2012. View at Google Scholar